Esraa Arabi

Esraa Arabi

Auto-generated profile, based on publicly available information

Esraa Arabi

Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia, ngha.med.sa

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
MIMohammed Ishaq
Mohammed Ishaq
EAEsraa Arabi
Esraa Arabi
AYAyman F. Yousef
Ayman F. Yousef
HAHaifa Almedbal
Haifa Almedbal
Introduction and importance: Pulmonary granular cell tumor (GCT) is a very rare neoplasm that originates from Schwann cells. Case presentation: Our case report describes a symptomatic benign pulmonary GCT found during follow-up CT imaging and was eventually excised with a good outcome. Clinical discussion: GCT are mostly benign tumors. Pulmonary GCTs mostly occur in the endobronchial region and can be symptomatic or discovered incidentally. Conclusion: Treatment options for pulmonary GCT are either conservative treatment or surgical resection depending on the size of the tumor and the presence of tracheal wall invasion. Highlights:

21 December 2021 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
MAMohammad Alamassi
Mohammad Alamassi
EAEsraa Arabi
Esraa Arabi
Introduction and importance: Spontaneous rupture of the trachea is a rare, life-threatening condition. Spontaneous rupture associated with corticosteroid use has been rarely reported in the literature. Case presentation: We report a case of a 17-year-old male, a known case of nephrotic syndrome managed by corticosteroid treatment, who presented with diffuse neck and chest swelling after forceful coughing resulting in a spontaneous rupture of the trachea. The diagnosis was established using radiological imaging. The patient was managed conservatively with significant improvement and was discharged shortly. Clinical discussion: Prolonged use of corticosteroids may lead to spontaneous rupture of the trachea due to tracheal wall weakness. Radiological imaging followed by bronchoscopy can be used to confirm the diagnosis. Management can either be conservative or surgical, depending on the case. Conclusion: Conservative treatment by pain relief, intravenous fluids, and antibiotics should be considered an alternative to surgery in selected patients. Highlights:

23 April 2024 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
MIMohammed S. Ishaq
Mohammed S. Ishaq
EAEsraa Y. Arabi
Esraa Y. Arabi
Objectives: To assess the prevalence, risk factors, and associated complications of pneumothorax that are present in patients with human immunodeficiency virus (HIV) at our institution and to provide an updated local study addressing the association between pneumothorax and HIV. Methods: This retrospective cohort study examined 161 patients who were admitted with a diagnosis of HIV from June 2017 to May 2022. They were divided into 2 groups depending on the presence of pneumothorax during their stay. Multiple variables were studied, including age, gender, tuberculosis infection, pneumocystis jiroveci pneumonia (PJP)infection, bacterial pneumonia, and pneumothorax type and treatment course. Results: There were 11 patients diagnosed with pneumothorax (prevalence rate: 6.8%). Bacterial lung infection was found in 9 (81.8%) of these patients, while fungal infection was found in 6 (54.5%) (p<0.001, 0.010). The MTB was found in 3 (27.3%) patients (p=0.728), while none were infected with PJP. Intercostal tube insertion was attempted in 9 (81.8%) patients, the mean duration of tube stay was 39.3±30.7 days, and the mortality rate was 72.7% (p=0.007). Conclusion: Pneumothorax in patients with HIV is a manifestation of the progression of the disease and its poor outcome. It has a complicated treatment course and a high mortality rate.

1 April 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MAMohammad Alamassi
Mohammad Alamassi
EAEsraa Yaseen Arabi
Esraa Yaseen Arabi
HAHaitham Arabi
Haitham Arabi
WSWaleed Saleh
Waleed Saleh
Carcinosarcoma of the esophagus constitutes only 0.5%–2.8% of all malignant esophageal cancers. It is identified by the presence of both carcinomatous and sarcomatous components. A clear regimen of treatment has not been established due to the limited understanding of the disease. We present a case of carcinosarcoma of the esophagus with rapid recurrence and invasion to the intrathoracic cavity only 6 weeks after esophagectomy. Carcinosarcoma carries a poor prognosis, as it has a late tendency of hematogenous spread with a high growth rate.

1 August 2018
Verified
Conference Paper
Open access
PDF file
EAEsraa Arabi
Esraa Arabi
AAAbeer Alkhathlan
Abeer Alkhathlan
RARazan Alfaiz
Razan Alfaiz
GAGhaida Almusallam
Ghaida Almusallam
YAYousof Alzahrani
Yousof Alzahrani
MAMohammad Arabi
Mohammad Arabi
Background: Inferior vena cava (IVC) filter is a device inserted in patients who are prone to develop pulmonary embolism (PE) and deep venous thrombosis (DVT). PE and DVT are one of the most common medical conditions present in patients who have venous thromboembolism. Venous thromboembolism begins as DVT in the lower limbs which detaches and travels through IVC. The clot ends up as PE blocking the heart and lung circulation. One in 10,000 people are diagnosed with PE and increases to 5 in 1000 by the age of 80 annually. PE leads to hypopnea, chest pain, tachycardia, and in severe cases heart failure, loss of consciousness, and death. In the United States, 25%–40% of cases reported with sudden death. The first line of the treatment is anticoagulants and blood thinning medications. Some neurological and cardiovascular conditions limit the efficacy of anticoagulants. Therefore, IVC filters are used as second-line treatment. In 1973, the first filter was used to replace surgical interventions to prevent thrombosis. The IVC filter has a conical shape ending with hooks to anchor it to the IVC wall. An effective filter has easy placement and can trap all thrombi to prevent new or recurrent PE without migration or perforation of IVC. IVC filter is mainly indicated when anticoagulation therapy is not effective, as in patients with trauma, hemorrhage, and other cardiac problems. However, it cannot be used in severe uncorrectable coagulopathy, prothrombotic state, and active bacteremia. IVC filters are designed with different durability, permanent, and retrievable, according to the patients' conditions. Permanent filters were mainly used in the past until retrievable filters were approved by the Food and Drug Administration (FDA) in 2003. Although retrievable filters are designed to be removed, in some cases, they become permanent due to lack of patient's compliance or poor monitoring. In Wellington Hospital, out of 5000 patients with IVC filters only 12%–45% of filters were retrieved. No local studies, in Saudi Arabia, are available. Leaving the filter longer than necessary may lead to several complications. The longer the filters are left in the body, the greater the chances that migration and malposition will occur. This tilting, or malpositioning, can result, in less common cases, in filter fracture. Failed retrieval can also be caused by a trapped clot. When more than 25% of the filter is filled with a clot, it cannot be removed. Instead, the patient is given anticoagulants for the following 1–2 months, the filter removal attempt is then repeated. Other long-term complications include IVC perforation, IVC occlusion, and developing DVT. To prevent further long-term placement complications that counter-affect the main purpose of inserting filters, the FDA urged health institutions to maximize the retrieval rates. At King Abdulaziz Medical City, the Vascular and Interventional Radiology department established a departmental form in January 1, 2015, to improve retrieval rates of IVC filters. The purpose of the study to compare retrieval rates before and after implementing the form to access its effectiveness. Methods: This is a case–control retrospective study of all patients who had retrievable IVC filter insertion 2 years before and after implementation of a departmental follow-up from June 2015. The departmental follow-up form includes the following information: Patient's name, age, sex, and medical record number. It also contains most responsible physician badge number and pager. IVC filter date of insertion and removal, filter type, and implementing physician name are also included. Subjects were retrospectively analyzed based on age, gender, indication, type of filter, date of filter insertion, location of insertion, date of retrieval, dwelling time, and previous attempts of retrieval. Results: Between June 2013 and May 2017, a total of 307 filters were inserted in 183 males (59.61%) and 124 females (40.39%) with mean age of 59 (SD 17.24). Of these filters, 296 (96.42%) were placed in an infrarenal location and 11 (3.58%) were placed as suprarenal filters. The types of the filters were as follows: 167 Optease (54.40%), 33 Option Elite (10.75%), 78 Denali (25.41%), 2 Capturex (0.65%), and 27 Celect (8.79%). A total of 148 (48.21%) filters were inserted before establishing the follow-up form, and 159 (51.79%) were inserted after the form. A total of 53 (35.81%) of those filters inserted before the form were retrieved, while 61 filters (38.36%) of those inserted after the form were. The mean dwelling time of retrieved filters before the form was 32 days and 48 days for the 2 years after the form implementation, with a standard deviation of 49.42. This increase was explained by the use of filters with longer dwelling time. Filter retrieval was successful in 110 patients (96.49%) from the first attempt and four patients (3.51%) required more than one attempt Conclusion: The departmental follow-up of patients who undergo IVC filters results in improvement of the retrievability rates. Publication Date: 11 May 2021 (online) © 2018. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

1 January 2026 in Qatar Medical Journal
Verified
Journal Article
Open access
EAEsraa Arabi
Esraa Arabi
AQAbdalrhman Qazli
Abdalrhman Qazli
AAAli Alamri
Ali Alamri
YAYazed Albogami
Yazed Albogami
FAFatmah Alsohaibani
Fatmah Alsohaibani
ZAZeyad Alyousef
Zeyad Alyousef
Background: Managing umbilical hernia in cirrhotic patients is complex. No prior national studies have examined the outcomes associated with treatment approaches for this demographic. Objectives: To evaluate the results of cirrhotic patients with umbilical hernia treated conservatively compared to those who underwent elective surgical hernia repair. Methodology: This is a retrospective cohort study conducted over 5 years period from January 2017 to December 2022 at King Abdulaziz Medical City and King Abdullah Specialized Children’s Hospital in Riyadh, Saudi Arabia. A comparison was conducted between those who underwent elective umbilical hernia repair and those treated conservatively. A chi-square test was used for categorical variables, while t-test and analysis of variance were used for numerical and categorical variables. Results: The study included 70 patients, out of which 54 patients initially planned for conservative treatment, and 21 eventually underwent emergent umbilical hernia repair. In the elective surgery group, 11 (68.8%) had a Child A score, whereas the emergency group had 9 patients (42.9%) with a Child B score and 10 patients (47.6%) with a Child C score ( p = 0.001). Post-operatively, 12 patients (57.1%) required intensive care unit (ICU) admissions in the emergency group compared to only 2 patients (12.5%) in the elective group ( p = 0.006). Conclusion: Expectant management of cirrhotic patients with umbilical hernia and ascites often results in a higher complication rate, frequently leading to emergency surgery, which is associated with significant morbidity. In contrast, elective hernia repair typically results in fewer complications and is therefore recommended.